Multi‐modal intervention for the inpatient management of sickle cell pain significantly decreases the rate of acute chest syndrome

Abstract

Introduction Pain in children with sickle cell disease (SCD) is the leading cause of acute care visits and hospitalizations. Pain episodes are a risk factor for the development of acute chest syndrome (ACS), contributing to morbidity and mortality in SCD. Few strategies exist to prevent this complication. Methods We performed a before‐and‐after prospective multi‐modal intervention. All children with SCD admitted for pain during the 2‐year study period were eligible. The multi‐modal intervention included standardized admission orders, monthly house staff education, and one‐on‐one patient and caregiver education. Results A total of 332 admissions for pain occurred during the study period; 159 before the intervention and 173 during the intervention. The ACS rate declined by 50% during the intervention period 25% (39 of 159) to 12% (21 of 173); P = 0.003. Time to ACS development increased from 0.8 days (0.03–5.2) to 1.7 days (0.03–5.8); P = 0.047. No significant difference was found in patient demographics, intravenous fluid amount administered, frequency of normal saline bolus administration, or cumulative opioid amount delivered in the first 24 hr. Patient controlled analgesia‐use was more common after the intervention 52% (82 of 159) versus 73% (126 of 173; P = 0.0001) and fewer patients required changes in analgesic dosing within the first 24 hr after admission (26%, 42 of 159 vs. 16%, 28 of 173; P = 0.015). Conclusions A multi‐modal intervention to educate and subsequently change physician's behavior likely decreased the rate of ACS in the setting of a single teaching hospital. Pediatr Blood Cancer 2011;56:262–266.